🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 14 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/03/2014 72,19 73,00 69,43 71,44 -0,64% 4,95% 261.500
12/03/2014 73,03 73,68 71,04 71,90 -2,43% 3,61% 301.100
11/03/2014 73,98 76,26 72,74 73,69 -0,51% 4,76% 332.200
10/03/2014 74,00 74,30 72,41 74,07 -0,48% 2,55% 326.700
07/03/2014 77,06 79,01 73,24 74,43 -2,64% 7,49% 460.400
06/03/2014 80,09 81,30 76,22 76,45 -4,71% 6,34% 393.900
05/03/2014 80,50 81,39 78,78 80,23 -0,25% 3,24% 341.500
04/03/2014 79,00 81,86 78,09 80,43 +2,38% 4,77% 444.800
03/03/2014 77,25 78,96 76,11 78,56 +0,41% 3,69% 283.500
28/02/2014 79,58 80,46 77,33 78,24 -1,32% 3,93% 470.000
27/02/2014 79,06 81,78 78,37 79,29 +1,59% 4,31% 595.900
26/02/2014 78,00 78,88 77,63 78,05 -0,12% 1,60% 786.300
25/02/2014 78,00 83,41 75,67 78,14 +6,56% 9,92% 987.500
24/02/2014 72,60 74,44 72,50 73,33 +1,61% 2,67% 453.100
21/02/2014 72,71 74,60 71,99 72,17 +0,40% 3,59% 321.800
20/02/2014 70,88 72,10 69,57 71,88 +1,97% 3,57% 370.700
19/02/2014 69,64 71,42 68,57 70,49 +1,31% 4,09% 500.500
18/02/2014 68,22 71,12 68,22 69,58 +2,29% 4,25% 484.500
14/02/2014 70,24 71,92 67,75 68,02 -2,97% 5,94% 362.700
13/02/2014 61,32 70,50 61,01 70,10 +13,30% 15,48% 1.030.300
12/02/2014 63,08 63,29 61,54 61,87 -1,96% 2,77% 642.000
11/02/2014 63,91 64,91 62,85 63,11 -1,25% 3,22% 488.100
10/02/2014 64,45 64,62 62,76 63,91 -0,53% 2,89% 290.200
07/02/2014 63,16 64,33 62,05 64,25 +2,16% 3,61% 377.200
06/02/2014 64,27 64,61 62,00 62,89 -1,58% 4,06% 316.800
05/02/2014 64,80 65,06 62,00 63,90 -1,56% 4,72% 362.700
04/02/2014 65,68 69,00 64,58 64,91 -0,60% 6,73% 244.900
03/02/2014 69,84 70,00 64,71 65,30 -4,71% 7,57% 634.900
31/01/2014 64,93 69,74 64,06 68,53 +3,44% 8,75% 652.500
30/01/2014 62,99 66,71 62,96 66,25 +6,79% 5,95% 594.900